Abiopharma

Jimmy Oakes & ENEOS Debuted Ferrari-Powered Porsche 911!

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/ Change in Interest of Substantial Shareholder

GlobalFoundries qualifies SLATE™ advanced packaging technology on 9SW platform for next-generation radio frequency applications

RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

Wearable Devices Publishes White Paper Positioning Wrist-Worn Neural Sensing as the "Intent Layer" for Agentic AI, AR, and Robotics

WISeKey and SEALSQ Welcome White House Executive Order on Quantum Security, Highlighting the Critical Three-Year Window to Prepare Society for Q-Day

Change – Announcement of Appointment::Appointment of Executive Director and Group Chief Executive Officer – Ong Choon Yi (Wang Junyi)

Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s)::Cessation of Substantial Shareholder – Yee Pinh Jeremy

Silexion Therapeutics Receives Approval from Germanys BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s)::Cessation of Substantial Shareholder – Chen Johnson